TABLE OF CONTENTS

Volume 10, Issue 10 (May 2003)

Top

Editorial

Targeting 'horror autotoxicus' by gene therapy: results, challenges and the future FREE

L Layward and Y Chernajovsky

Gene Ther 10: 833-834; doi:10.1038/sj.gt.3302022

Top

Reviews

Celiac Disease: a model autoimmune disease with gene therapy applications FREE

M Londei, S Quaratino and L Maiuri

Gene Ther 10: 835-843; doi:10.1038/sj.gt.3302041

Gene therapy in autoimmune, demyelinating disease of the central nervous system FREE

David Baker and D J R Hankey

Gene Ther 10: 844-853; doi:10.1038/sj.gt.3302025

Gene transfer approaches for the treatment of inflammatory bowel disease FREE

S Wirtz and M F Neurath

Gene Ther 10: 854-860; doi:10.1038/sj.gt.3302013

Immunopathology and the gene therapy of lupus FREE

R A Mageed and G J Prud'homme

Gene Ther 10: 861-874; doi:10.1038/sj.gt.3302016

Gene- and cell-based therapeutics for type I diabetes mellitus FREE

R Bottino, P Lemarchand, M Trucco and N Giannoukakis

Gene Ther 10: 875-889; doi:10.1038/sj.gt.3302015

Gene therapy in nonhuman primate models of human autoimmune disease FREE

B A t'Hart, M Vervoordeldonk, J L Heeney and P P Tak

Gene Ther 10: 890-901; doi:10.1038/sj.gt.3302017

Gene therapy for arthritis FREE

P D Robbins, C H Evans and Y Chernajovsky

Gene Ther 10: 902-911; doi:10.1038/sj.gt.3302040

Vectors for the treatment of autoimmune disease FREE

D J Gould and P Favorov

Gene Ther 10: 912-927; doi:10.1038/sj.gt.3302018

Engineering mesenchymal stem cells for immunotherapy FREE

C Jorgensen, F Djouad, F Apparailly and D Noël

Gene Ther 10: 928-931; doi:10.1038/sj.gt.3302019

Extra navigation

.
ADVERTISEMENT